Literature DB >> 19199007

Phosphorylation on Thr-106 and NO-modification of glyoxalase I suppress the TNF-induced transcriptional activity of NF-kappaB.

Virginie de Hemptinne1, Dieter Rondas, Mascha Toepoel, Katia Vancompernolle.   

Abstract

Glyoxalase I (GLO1), together with glyoxalase II and the co-factor GSH, comprise the glyoxalase system, which is responsible for the detoxification of the cytotoxic glycolytic-derived metabolite methylglyoxal (MG). We, and others, have previously reported that GLO1 is subjected to several post-translational modifications, including a NO-mediated modification and phosphorylation. In this study, we demonstrate that GLO1 is a substrate for calcium, calmodulin-dependent protein kinase II (CaMKII). Site-directed mutagenesis of several serine and threonine residues revealed that CaMKII induced phosphorylation of GLO1 at a single site Thr-106. Mutagenesis of Thr-106 to Ala in GLO1 completely abolished the CaMKII-mediated phosphorylation. A phosphopeptide bracketing phosphothreonine-106 in GLO1 was used as an antigen to generate polyclonal antibodies against phosphothreonine-106. By using this phospho-specific antibody, we demonstrated that TNF induces phosphorylation of GLO1 on Thr-106. Furthermore, we investigated the role of NO-mediated modification and phosphorylation of GLO1 in the TNF-induced transcriptional activity of NF-kappaB. Overexpression of WT GLO1 suppressed TNF-induced NF-kappaB-dependent reporter gene expression. Suppression of the basal and TNF-induced NF-kappaB activity was significantly stronger upon expression of a GLO1 mutant that was either deficient for the NO-mediated modification or phosphorylation on Thr-106. However, upon overexpression of a GLO1 mutant that was deficient for both types of modification, the suppressive effect of GLO1 on TNF-induced NF-kappaB activity was completely abolished. These results suggest that NO-modification and phosphorylation of GLO1 contribute to the suppression of TNF-induced NF-kappaB-dependent reporter gene expression. In line with this, knock-down of GLO1 by siRNA significantly increased TNF-induced NF-kappaB-dependent reporter gene expression. These findings suggest that phosphorylation and NO-modification of glyoxalase I provides another control mechanism for modulating the basal and TNF-induced expression of NF-kappaB-responsive genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199007     DOI: 10.1007/s11010-009-0031-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  Phosphoproteomic identification of targets of the Arabidopsis sucrose nonfermenting-like kinase SnRK2.8 reveals a connection to metabolic processes.

Authors:  Ryoung Shin; Sophie Alvarez; Adrien Y Burch; Joseph M Jez; Daniel P Schachtman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

2.  Crystal structure of human glyoxalase I--evidence for gene duplication and 3D domain swapping.

Authors:  A D Cameron; B Olin; M Ridderström; B Mannervik; T A Jones
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

3.  Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis.

Authors:  H Sakamoto; T Mashima; A Kizaki; S Dan; Y Hashimoto; M Naito; T Tsuruo
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

4.  Sexual response of Saccharomyces cerevisiae: phosphorylation of yeast glyoxalase I by a cell extract of mating factor-treated cells.

Authors:  Y Inoue; B Y Choi; K Murata; A Kimura
Journal:  J Biochem       Date:  1990-07       Impact factor: 3.387

5.  Tumor necrosis factor-induced microtubule stabilization mediated by hyperphosphorylated oncoprotein 18 promotes cell death.

Authors:  K Vancompernolle; T Boonefaes; M Mann; W Fiers; J Grooten
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

6.  Tumour necrosis factor induces phosphorylation primarily of the nitric-oxide-responsive form of glyoxalase I.

Authors:  Virginie de Hemptinne; Dieter Rondas; Joël Vandekerckhove; Katia Vancompernolle
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

Review 7.  Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy.

Authors:  P J Thornalley
Journal:  Gen Pharmacol       Date:  1996-06

8.  Cloning and characterization of human colon glyoxalase-I.

Authors:  S Ranganathan; E S Walsh; A K Godwin; K D Tew
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

9.  Involvement of Ca2+/calmodulin-dependent protein kinase II in endothelial NO production and endothelium-dependent relaxation.

Authors:  Jean-Christophe Schneider; Driss El Kebir; Christiane Chéreau; Sophie Lanone; Xiao-Lin Huang; Anthony S De Buys Roessingh; Jean-Christophe Mercier; Josette Dall'Ava-Santucci; A Tuan Dinh-Xuan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-01-30       Impact factor: 4.733

10.  Chemical genetic analysis of the time course of signal transduction by JNK.

Authors:  Juan-Jose Ventura; Anette Hübner; Chao Zhang; Richard A Flavell; Kevan M Shokat; Roger J Davis
Journal:  Mol Cell       Date:  2006-03-03       Impact factor: 17.970

View more
  8 in total

1.  Ameliorating Methylglyoxal-Induced Progenitor Cell Dysfunction for Tissue Repair in Diabetes.

Authors:  Hainan Li; Megan O'Meara; Xiang Zhang; Kezhong Zhang; Berhane Seyoum; Zhengping Yi; Randal J Kaufman; Terrence J Monks; Jie-Mei Wang
Journal:  Diabetes       Date:  2019-03-18       Impact factor: 9.461

2.  Glyoxalase I is differentially expressed in cutaneous neoplasms and contributes to the progression of squamous cell carcinoma.

Authors:  Xiao-Yan Zou; Dong Ding; Na Zhan; Xiao-Ming Liu; Cheng Pan; Yu-Min Xia
Journal:  J Invest Dermatol       Date:  2014-09-03       Impact factor: 8.551

Review 3.  Metabolic Shades of S-D-Lactoylglutathione.

Authors:  Miklós Péter Kalapos; Cinzia Antognelli; Lidia de Bari
Journal:  Antioxidants (Basel)       Date:  2022-05-20

4.  Posttranslational modification of human glyoxalase 1 indicates redox-dependent regulation.

Authors:  Gerd Birkenmeier; Christin Stegemann; Ralf Hoffmann; Robert Günther; Klaus Huse; Claudia Birkemeyer
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

5.  Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects.

Authors:  Kyle P Smith; Kathleen M Gifford; Joshua S Waitzman; Sarah E Rice
Journal:  Proteins       Date:  2014-11-18

6.  Morphological and proteomic analyses reveal that unsaturated guluronate oligosaccharide modulates multiple functional pathways in murine macrophage RAW264.7 cells.

Authors:  Xu Xu; De-Cheng Bi; Chao Li; Wei-Shan Fang; Rui Zhou; Shui-Ming Li; Lian-Li Chi; Min Wan; Li-Ming Shen
Journal:  Mar Drugs       Date:  2015-03-30       Impact factor: 5.118

7.  Temporal dynamics of glyoxalase 1 in secondary neuronal injury.

Authors:  Philipp Pieroh; Marco Koch; Daniel-Christoph Wagner; Johannes Boltze; Angela Ehrlich; Chalid Ghadban; Constance Hobusch; Gerd Birkenmeier; Faramarz Dehghani
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

Review 8.  Glyoxalases in Urological Malignancies.

Authors:  Cinzia Antognelli; Vincenzo Nicola Talesa
Journal:  Int J Mol Sci       Date:  2018-01-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.